BioNTech plans UK trial of mRNA cancer therapy
The project is part of a new agreement with the British government focused on "cancer immunotherapies, infectious disease vaccines, and expansion of BioNTech's footprint in the UK", the company said.
PREMIUM Health
BioNTech will also open a new research and development centre with around 70 staff in Cambridge. (AFP)
NewVision Reporter
@NewVision
German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.
Up to 10,000 people